Pharmaceuticals in Singapore
SummaryPharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.
- The Singaporean pharmaceuticals market recorded revenues of $7.3 billion in 2024, representing a compound annual growth rate (CAGR) of 4.9% between 2019 and 2024.
- The central nervous system drugs segment accounted for the market's largest proportion in 2024, with total revenues of $1.2 billion, equivalent to 17.0% of the market's overall value.
- Singapore captured a share of 2.0% in the Asia-Pacific pharmaceuticals market in 2024. According to the data from Statistics Singapore, the population in Singapore reached 6.0 million in 2024 from 5.9 million in 2023. The rising population resulted in an
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Singapore
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Singapore
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Singapore pharmaceuticals market with five year forecasts
Reasons To Buy
- What was the size of the Singapore pharmaceuticals market by value in 2024?
- What will be the size of the Singapore pharmaceuticals market in 2029?
- What factors are affecting the strength of competition in the Singapore pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Singapore's pharmaceuticals market?
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.